Avenir Corp

13F Holdings History for Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO)

Symbol: CTSO on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Ownership: 3.09M shares
Security Ownership: 5.7%

Shares, Excluding Options vs Price

Value, Excluding Options

AVENIR CORP ownership in Cytosorbents Corp Common Stock, par value $0.001 per share (CTSO)

2025-02-14 - AVENIR CORP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3.09M shares of Cytosorbents Corp Common Stock, par value $0.001 per share (CTSO). This represents 5.7% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
AVENIR CORP	5.7%		$3.09M	3.09M			$1.00	13G/A	12/31/2024	14 Feb 2025 10:22:49

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0.49%	+0%	$4.75M	5.08M	+24,301	+0.48%	$0.93	Q3 2025
6/30/2025	0.67%	+0%	$6.47M	5.06M	+13,619	+0.27%	$1.28	Q2 2025
3/31/2025	0.53%	+0.2%	$5.04M	5.04M	+1,950,972		$1.00	Q1 2025
12/31/2024	0.29%	+0.01%	$2.82M	3.09M	+118,387	+3.98%	$0.91	Q4 2024
9/30/2024	0.45%	+0%	$4.46M	2.98M	+5,297	+0.18%	$1.50	Q3 2024
6/30/2024	0.2%	-0.01%	$2.09M	2.97M	-202,434	-6.38%	$0.70	Q2 2024
3/31/2024	0.26%	+0.01%	$3.01M	3.17M	+121,294	+3.98%	$0.95	Q1 2024
12/31/2023	0.29%	+0.03%	$3.39M	3.05M	+334,005	+12.3%	$1.11	Q4 2023
9/30/2023	0.48%	0%	$5.11M	2.72M	-2,335	-0.09%	$1.88	Q3 2023
6/30/2023	0.86%	+0.05%	$9.76M	2.72M	+164,179	+6.42%	$3.59	Q2 2023
3/31/2023	0.81%	+0.03%	$8.61M	2.56M	+108,464	+4.43%	$3.37	Q1 2023
12/31/2022	0.38%	+0.02%	$3.79M	2.45M	+132,235	+5.71%	$1.55	Q4 2022
9/30/2022	0.33%	+0.02%	$3.15M	2.31M	+149,855	+6.92%	$1.36	Q3 2022
6/30/2022	0.45%	0%	$4.74M	2.16M	-11,510	-0.53%	$2.19	Q2 2022
3/31/2022	0.55%	+0.1%	$6.94M	2.18M	+389,234	+21.8%	$3.19	Q1 2022
12/31/2021	0.58%	+0.13%	$7.49M	1.79M	+391,890	+28.1%	$4.19	Q4 2021
9/30/2021	0.95%	+0.02%	$11.3M	1.4M	+28,836	+2.11%	$8.12	Q3 2021
6/30/2021	0.82%	+0.66%	$10.3M	1.37M	+1,007,679	+281%	$7.55	Q2 2021
3/31/2021	0.27%	+0.13%	$3.12M	359K	+152,130	+73.6%	$8.68	Q1 2021
12/31/2020	0.16%	+0.01%	$1.65M	207K	+16,500	+8.67%	$7.97	Q4 2020
9/30/2020	0.16%	+0.02%	$1.52M	190K	+22,520	+13.4%	$7.97	Q3 2020
6/30/2020	0.19%	+0.02%	$1.66M	168K	+17,120	+11.4%	$9.90	Q2 2020
3/31/2020	0.16%		$1.16M	151K			$7.73	Q1 2020
12/31/2019	0.06%		$580K	151K			$3.85	Q4 2019
9/30/2019	0.08%	+0%	$758K	151K	+5,300	+3.65%	$5.03	Q3 2019
6/30/2019	0.1%	+0.04%	$960K	145K	+58,060	+66.6%	$6.61	Q2 2019
3/31/2019	0.07%	+0.01%	$660K	87.2K	+10,850	+14.2%	$7.57	Q1 2019
12/31/2018	0.08%	+0.03%	$617K	76.4K	+34,135	+80.8%	$8.08	Q4 2018
9/30/2018	0.06%	+0.02%	$545K	42.3K	+11,185	+36%	$12.90	Q3 2018
6/30/2018	0.04%	+0.04%	$354K	31.1K	+31,070	NEW	$11.39	Q2 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.